Case series and review of Ayurvedic medication induced liver injury
Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of dr...
Saved in:
Published in | BMC complementary and alternative medicine Vol. 21; no. 1; p. 91 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
13.03.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury.
Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury.
These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. |
---|---|
AbstractList | Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury.
Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury.
These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90–120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7–8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. Keywords: Ayurveda, Ayurvedic medicine, Drug induced liver injury (DILI), Herb induced liver injury (HILI), Traditional Chinese medicine, Roussel Uclaf causality assessment method BACKGROUNDComplementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. CASE PRESENTATIONSThree patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90-120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7-8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. CONCLUSIONSThese patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90–120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7–8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002. CAM accounts for a significant proportion of drug induced liver injury in India and China, but there have been only three reports of drug induced liver injury from Ayurvedic medications in the U.S. We report three cases of suspected Ayurvedic medication associated liver injury seen at a Southern California community hospital and review literature of Ayurvedic medication induced liver injury. Case presentations Three patients presented with acute hepatocellular injury and jaundice after taking Ayurvedic supplements for 90–120 days. First patient took Giloy Kwath consisting solely of Tinospora cordifolia. Second patient took Manjishthadi Kwatham and Aragwadhi Kwatham, which contained 52 and 10 individual plant extracts, respectively. Third patient took Kanchnar Guggulu, containing 10 individual plant extracts. Aminotransferase activities decreased 50% in < 30 days and all 3 patients made a full recovery. Roussel Uclaf Causality Assessment Method (RUCAM) scores were 7–8, indicating probable causality. These products all contained ingredients in other Ayurvedic and traditional Chinese medicines with previously reported associations with drug induced liver injury. Conclusions These patients highlight the risk of drug induced liver injury from Ayurvedic medications and the complexity of determining causality. There is a need for a platform like LiverTox.gov to catalog Ayurvedic ingredients causing liver damage. |
ArticleNumber | 91 |
Audience | Academic |
Author | Karousatos, Christopher M Fong, Tse-Ling Lee, Justin K Braxton, David R |
Author_xml | – sequence: 1 givenname: Christopher M surname: Karousatos fullname: Karousatos, Christopher M organization: Keck School of Medicine, University of Southern California, Los Angeles, CA, USA – sequence: 2 givenname: Justin K surname: Lee fullname: Lee, Justin K organization: Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA – sequence: 3 givenname: David R surname: Braxton fullname: Braxton, David R organization: Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA – sequence: 4 givenname: Tse-Ling orcidid: 0000-0001-9020-4880 surname: Fong fullname: Fong, Tse-Ling email: tselingf@usc.edu, tselingf@usc.edu organization: Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, 1510 San Pablo Street, 2/F, Los Angeles, CA, 90033, USA. tselingf@usc.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33714265$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl1rFDEUhoNUbK39A17IgCDeTM3HJJm5EZbFj0LBG70OmeRkN8tsUpOZle2vN9OtdVckkM_nvCc5eV-isxADIPSa4GtCWvEhE9phUWNKaswoJ_X9M3RBhaC1FJKcHc3P0VXOG4wxZYRJxl-gc8YkaajgF2i51BmqDMlDrnSwVYKdh19VdNViP6UdWG-q7dzr0cdQ-WAnA7Ya_A5SWW2mtH-Fnjs9ZLh6HC_Rj8-fvi-_1rffvtwsF7e14V0z1rLF1jS0peBsI7k1WlgOBgTTVvBeS9oT5gwHEIS4rrdSth0G6IjsheOYXaKbg66NeqPukt_qtFdRe_WwEdNK6TR6M4CSzvak6LTO9E0HXW90yUka6wQTruNF6-NB627qy_MMhDHp4UT09CT4tVrFnZIdL9ebBd4_CqT4c4I8qq3PBoZBB4hTVpRj0hRYyoK-_QfdxCmFUqqZooJ0mDV_qZUuD_DBxZLXzKJqITinpCFCFOr6P1RpFrbeFIs4X_ZPAt4dBaxBD-M6x2GafzOfgvQAmhRzTuCeikGwmi2nDpZTxXLqwXLqvgS9OS7jU8gfg7Hfi9TR1g |
CitedBy_id | crossref_primary_10_1016_j_jaim_2022_100635 crossref_primary_10_1016_j_jceh_2021_06_021 crossref_primary_10_3390_ph16081129 crossref_primary_10_18231_j_sajcrr_2024_003 crossref_primary_10_1016_j_jceh_2021_08_020 crossref_primary_10_4254_wjh_v13_i9_1019 crossref_primary_10_1016_j_jceh_2021_08_026 crossref_primary_10_1016_j_jceh_2021_09_009 crossref_primary_10_1002_cld_1135 crossref_primary_10_18311_jnr_2023_34070 crossref_primary_10_1007_s12664_024_01589_z crossref_primary_10_3390_nu14224723 crossref_primary_10_1080_15569543_2021_1925696 crossref_primary_10_1016_j_jceh_2022_11_001 crossref_primary_10_4103_ijamr_ijamr_181_23 crossref_primary_10_1016_j_jceh_2021_11_014 crossref_primary_10_1055_s_0042_1758663 crossref_primary_10_2478_pjst_2023_0022 |
Cites_doi | 10.1155/2012/504507 10.3390/ijms17010114 10.3390/ijms17010014 10.1111/j.1478-3231.2012.02864.x 10.1177/1534735419869479 10.1111/apt.12109 10.1002/hep.27317 10.1016/S1665-2681(19)30796-3 10.1186/1756-8722-4-51 10.1016/j.jep.2016.09.024 10.1016/j.jtcme.2016.02.002 10.4103/0022-3859.128819 10.1016/j.dld.2010.12.012 10.1111/apt.12798 10.1111/jgh.13323 10.1111/j.1468-1331.2011.03373.x 10.1007/s12664-017-0815-8 10.1136/bcr-2013-200958 10.4103/0975-9476.90769 10.1016/S1665-2681(19)31777-6 10.1007/0-306-48094-8_4 10.1089/acm.2008.0106 10.1097/MAJ.0b013e3181f41168 10.1111/head.12363 10.1016/j.healthpol.2008.09.003 10.1111/liv.14393 10.4321/S1130-01082005000200006 10.1016/j.toxrep.2020.02.008 10.1038/s41395-018-0154-0 10.1016/j.jep.2019.01.006 10.4254/wjh.v9.i31.1205 10.1002/jat.3283 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | NPM AAYXX CITATION 3V. 7TK 7U7 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12906-021-03251-z |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Toxicology Abstracts Proquest Health & Medical Complete ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Toxicology Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Central China ProQuest Hospital Collection (Alumni) Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2662-7671 1472-6882 |
EndPage | 91 |
ExternalDocumentID | oai_doaj_org_article_7fdb1e618fcb49e9bcad4714df636f95 A655214166 10_1186_s12906_021_03251_z 33714265 |
Genre | Journal Article |
GeographicLocations | China Timor-Leste India United States--US |
GeographicLocations_xml | – name: China – name: India – name: Timor-Leste – name: United States--US |
GroupedDBID | 53G 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABUWG ACRMQ ADUKV AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS BENPR BMC C24 C6C CCPQU EBLON EBS EMB EMOBN FYUFA GROUPED_DOAJ HMCUK IAO IHR IHW INH ITC M1P M~E NPM PGMZT PIMPY PSQYO ROL RPM RSV SOJ SV3 UKHRP AAYXX CITATION AFGXO ABVAZ AFNRJ --- -A0 0R~ 23N 2WC 3V. 5VS 6J9 6PF 7TK 7U7 7XB 8FK A8Z AAHBH AAWTL ACGFO ACGFS ACMJI ACPRK ADBBV ADINQ ADRAZ AENEX AFRAH AHBYD AHMBA AHYZX ALIPV AMKLP AOIJS AZQEC BAWUL BCNDV BFQNJ BPHCQ BVXVI C1K CS3 DIK DU5 DWQXO E3Z F5P GX1 HYE INR K9. KQ8 O5R O5S OK1 P2P PQEST PQQKQ PQUKI PRINS PROAC RBZ RNS SMD TR2 UNMZH W2D WOQ WOW XSB 7X8 5PM |
ID | FETCH-LOGICAL-c594t-780dc4282efd475dca6d5ece63ad65ba72b13fc5ee611f9bd77890ee917b6f503 |
IEDL.DBID | RPM |
ISSN | 2662-7671 |
IngestDate | Fri Oct 04 13:06:52 EDT 2024 Tue Sep 17 21:27:00 EDT 2024 Sat Aug 17 02:14:44 EDT 2024 Fri Sep 13 08:39:11 EDT 2024 Thu Feb 22 23:31:28 EST 2024 Sat Dec 16 00:16:22 EST 2023 Tue Aug 20 22:11:14 EDT 2024 Thu Sep 26 18:03:48 EDT 2024 Sat Sep 28 08:23:58 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Roussel Uclaf causality assessment method Traditional Chinese medicine Herb induced liver injury (HILI) Ayurveda Drug induced liver injury (DILI) Ayurvedic medicine |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c594t-780dc4282efd475dca6d5ece63ad65ba72b13fc5ee611f9bd77890ee917b6f503 |
Notes | ObjectType-Case Study-3 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Review-1 ObjectType-Feature-5 ObjectType-Report-2 ObjectType-Article-4 |
ORCID | 0000-0001-9020-4880 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956115/ |
PMID | 33714265 |
PQID | 2502619034 |
PQPubID | 44230 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7fdb1e618fcb49e9bcad4714df636f95 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7956115 proquest_miscellaneous_2501479577 proquest_journals_2502619034 gale_infotracmisc_A655214166 gale_infotracacademiconefile_A655214166 gale_healthsolutions_A655214166 crossref_primary_10_1186_s12906_021_03251_z pubmed_primary_33714265 |
PublicationCentury | 2000 |
PublicationDate | 2021-03-13 |
PublicationDateYYYYMMDD | 2021-03-13 |
PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-13 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC complementary and alternative medicine |
PublicationTitleAlternate | BMC Complement Med Ther |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 3251_CR6 CA Philips (3251_CR27) 2018; 37 HC Chow (3251_CR33) 2019; 18 JH Byeon (3251_CR37) 2019; 233 3251_CR3 A Chaudhary (3251_CR7) 2011; 2 Y Zhu (3251_CR15) 2016; 31 VJ Navarro (3251_CR16) 2014; 60 YE Satow (3251_CR10) 2008; 14 3251_CR26 HA Oketch-Rabah (3251_CR36) 2020; 7 S Giri (3251_CR35) 2014; 60 C Bunchorntavakul (3251_CR34) 2013; 37 X Lin (3251_CR12) 2016; 36 A Shiyovich (3251_CR25) 2010; 340 YS Jaiswal (3251_CR5) 2016; 7 A Douros (3251_CR19) 2016; 17 HK Björnsson (3251_CR18) 2020; 40 T Smith (3251_CR8) 2019; 123 H Tremlett (3251_CR23) 2011; 18 PK Mukherjee (3251_CR1) 2017; 197 RL Nahin (3251_CR9) 2016; 95 KK Dalal (3251_CR29) 2017; 9 J Xu (3251_CR13) 2009; 90 R Teschke (3251_CR20) 2009; 8 R Teschke (3251_CR28) 2012; 32 PM Barnes (3251_CR4) 2008; 12 CA Philips (3251_CR11) 2019; 7 DA Smith (3251_CR21) 2014; 2014 R Teschke (3251_CR32) 2014; 40 KS Gunturu (3251_CR30) 2011; 4 R Teschke (3251_CR31) 2015; 14 S Dantuluri (3251_CR22) 2011; 43 T Gokani (3251_CR2) 2014; 54 CA Philips (3251_CR17) 2018; 113 JL McQuade (3251_CR14) 2012; 2012 OA Jorge (3251_CR24) 2005; 97 |
References_xml | – volume: 2012 start-page: 504507 year: 2012 ident: 3251_CR14 publication-title: Evid Based Complement Alternat Med doi: 10.1155/2012/504507 contributor: fullname: JL McQuade – volume: 17 start-page: 114 issue: 1 year: 2016 ident: 3251_CR19 publication-title: Int J Mol Sci doi: 10.3390/ijms17010114 contributor: fullname: A Douros – ident: 3251_CR26 doi: 10.3390/ijms17010014 – volume: 32 start-page: 1543 issue: 10 year: 2012 ident: 3251_CR28 publication-title: Liver Int doi: 10.1111/j.1478-3231.2012.02864.x contributor: fullname: R Teschke – volume: 18 start-page: 153473541986947 year: 2019 ident: 3251_CR33 publication-title: Integr Cancer Ther doi: 10.1177/1534735419869479 contributor: fullname: HC Chow – volume: 37 start-page: 3 issue: 1 year: 2013 ident: 3251_CR34 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12109 contributor: fullname: C Bunchorntavakul – volume: 12 start-page: 1 year: 2008 ident: 3251_CR4 publication-title: Natl Health Stat Report. contributor: fullname: PM Barnes – volume: 60 start-page: 1399 issue: 4 year: 2014 ident: 3251_CR16 publication-title: Hepatology. doi: 10.1002/hep.27317 contributor: fullname: VJ Navarro – volume: 14 start-page: 7 issue: 1 year: 2015 ident: 3251_CR31 publication-title: Ann Hepatol doi: 10.1016/S1665-2681(19)30796-3 contributor: fullname: R Teschke – volume: 123 start-page: 62 year: 2019 ident: 3251_CR8 publication-title: American Botanical Council contributor: fullname: T Smith – volume: 7 start-page: 263 issue: 3 year: 2019 ident: 3251_CR11 publication-title: J Clin Transl Hepatol contributor: fullname: CA Philips – volume: 4 start-page: 51 year: 2011 ident: 3251_CR30 publication-title: J Hematol Oncol doi: 10.1186/1756-8722-4-51 contributor: fullname: KS Gunturu – volume: 197 start-page: 10 year: 2017 ident: 3251_CR1 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2016.09.024 contributor: fullname: PK Mukherjee – volume: 7 start-page: 50 issue: 1 year: 2016 ident: 3251_CR5 publication-title: J Tradit Complement Med doi: 10.1016/j.jtcme.2016.02.002 contributor: fullname: YS Jaiswal – volume: 60 start-page: 72 issue: 1 year: 2014 ident: 3251_CR35 publication-title: J Postgrad Med doi: 10.4103/0022-3859.128819 contributor: fullname: S Giri – volume: 43 start-page: 500 issue: 6 year: 2011 ident: 3251_CR22 publication-title: Dig Liver Dis doi: 10.1016/j.dld.2010.12.012 contributor: fullname: S Dantuluri – volume: 40 start-page: 32 issue: 1 year: 2014 ident: 3251_CR32 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12798 contributor: fullname: R Teschke – volume: 31 start-page: 1476 issue: 8 year: 2016 ident: 3251_CR15 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.13323 contributor: fullname: Y Zhu – volume: 18 start-page: e78 issue: 7 year: 2011 ident: 3251_CR23 publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2011.03373.x contributor: fullname: H Tremlett – volume: 37 start-page: 9 issue: 1 year: 2018 ident: 3251_CR27 publication-title: Indian J Gastroenterol doi: 10.1007/s12664-017-0815-8 contributor: fullname: CA Philips – volume: 2014 start-page: bcr2013200958 year: 2014 ident: 3251_CR21 publication-title: BMJ Case Rep doi: 10.1136/bcr-2013-200958 contributor: fullname: DA Smith – volume: 2 start-page: 179 issue: 4 year: 2011 ident: 3251_CR7 publication-title: J Ayurveda Integr Med doi: 10.4103/0975-9476.90769 contributor: fullname: A Chaudhary – volume: 8 start-page: 258 issue: 3 year: 2009 ident: 3251_CR20 publication-title: Ann Hepatol doi: 10.1016/S1665-2681(19)31777-6 contributor: fullname: R Teschke – ident: 3251_CR3 doi: 10.1007/0-306-48094-8_4 – volume: 14 start-page: 1249 issue: 10 year: 2008 ident: 3251_CR10 publication-title: J Altern Complement Med doi: 10.1089/acm.2008.0106 contributor: fullname: YE Satow – volume: 340 start-page: 514 issue: 6 year: 2010 ident: 3251_CR25 publication-title: Am J Med Sci doi: 10.1097/MAJ.0b013e3181f41168 contributor: fullname: A Shiyovich – volume: 54 start-page: 1103 issue: 6 year: 2014 ident: 3251_CR2 publication-title: Headache. doi: 10.1111/head.12363 contributor: fullname: T Gokani – volume: 90 start-page: 133 issue: 2–3 year: 2009 ident: 3251_CR13 publication-title: Health Policy doi: 10.1016/j.healthpol.2008.09.003 contributor: fullname: J Xu – volume: 95 start-page: 1 year: 2016 ident: 3251_CR9 publication-title: Natl Health Stat Report contributor: fullname: RL Nahin – ident: 3251_CR6 – volume: 40 start-page: 825 issue: 4 year: 2020 ident: 3251_CR18 publication-title: Liver Int doi: 10.1111/liv.14393 contributor: fullname: HK Björnsson – volume: 97 start-page: 115 issue: 2 year: 2005 ident: 3251_CR24 publication-title: Rev Esp Enferm Dig doi: 10.4321/S1130-01082005000200006 contributor: fullname: OA Jorge – volume: 7 start-page: 386 year: 2020 ident: 3251_CR36 publication-title: Toxicol Rep doi: 10.1016/j.toxrep.2020.02.008 contributor: fullname: HA Oketch-Rabah – volume: 113 start-page: 1260 issue: 8 year: 2018 ident: 3251_CR17 publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0154-0 contributor: fullname: CA Philips – volume: 233 start-page: 190 year: 2019 ident: 3251_CR37 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2019.01.006 contributor: fullname: JH Byeon – volume: 9 start-page: 1205 issue: 31 year: 2017 ident: 3251_CR29 publication-title: World J Hepatol doi: 10.4254/wjh.v9.i31.1205 contributor: fullname: KK Dalal – volume: 36 start-page: 1163 issue: 9 year: 2016 ident: 3251_CR12 publication-title: J Appl Toxicol doi: 10.1002/jat.3283 contributor: fullname: X Lin |
SSID | ssj0002313735 ssj0017814 |
Score | 2.2731743 |
SecondaryResourceType | review_article |
Snippet | Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since... Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States... Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown... BACKGROUNDComplementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown... Abstract Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 91 |
SubjectTerms | Abdomen Alternative medicine Antibodies Asian Americans Ayurveda Ayurvedic medicine Bile Biological products Case Report Case reports Causality Chinese medicine Dietary supplements Drug induced liver injury (DILI) Drugs Flowers & plants Hepatitis A Herb induced liver injury (HILI) Herbal medicine Hypothyroidism Ingredients Injuries Jaundice Literature reviews Liver Liver diseases Medicine, Ayurvedic Medicine, Chinese Patients Plant extracts Roussel Uclaf causality assessment method Traditional Chinese medicine Ultrasonic imaging |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eirs92V40geJBmO51X5zgOLouwnlzYW8gTXaRHdmYE99dblfQM03jw4rEnNU3nq1SqqlP1NSHvQj-wnPvUCs1dK7yDfTAr03aReZVNYD7jie7lF3VxJT5fy-uDT31hTVilB67AnekcPUuKDTl4YZLxwUXYUEXMisPNKnspkwfJ1E0hcWFcc7nrkhnU2RpfuGC9LVYQgVNv72aeqBD2_70tH_ilec3kgRM6f0QeTtEjXdSnPib30viY3L-czsefkOUSnBLFVZXW1I2R1s4Uusp08Xt7-wsFaTlOLwqhkJCDaiP9gdUZcHUDCD8lV-efvi4v2ukzCW2QRmxaPXQxQBbRpwzIyBicijKFpLiLSgL6vWc8B5kARZaNjxqbX1OCRA3UITv-jByNqzG9IFSD-4bbZO2MEUjUHgcIUDo-OKP72PmGfNhBZn9WNgxbsohB2QqwBYBtAdjeNeQjorqXRCbr8gPo1076tf_Sb0PeoE5sbQvd26NdKAmRB4STqiHviwRaJKgmuKmxAKaE3FYzydOZJFhSmA_v9G4nS15bCBExyey4aMjb_TD-E6vTxrTaFhkmtJFaN-R5XSb7SXOkROwVzEPPFtAMlfnI-P1b4fnW2HTM5Mv_AeMJedDXtd8yfkqONrfb9ArCqY1_XSznD5FVHVk priority: 102 providerName: Directory of Open Access Journals – databaseName: Proquest Health & Medical Complete dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3JitVAsBlHEC_ibsZRWxA8SHjppJfkJM-Hw0MYTw68W9OrC5KMbxFmvt6qzuIEwWPSldC1dVV1V1UT8saVNYuxDDlXlcm5NbAORtnkhWdWxsYxG_FE9_yzXF_wTxuxOSLrsRYG0yrHNTEt1L5zuEe-AFONzn5R8YWxuAvg9ov3l79yvD8Kz1mHyzRukdusBLcCJFttptCLYWOnsWSmlosd7r5g8i2mE4GFz69nZil17_93jb5hpOYJlDcs0tl9cm9wJemy5_0DchTah-TO-XBY_oisVmChKIpY2FHTetqXqdAu0uXVYfsbAWk6W0_coRCdA589_YmpGvD0A8j9mFycffyyWufDnQm5Ew3f56ouvIOQogzRcyW8M9KL4IKsjJcCWFFaVkUnQpCMxcZ6hZWwIUDUBrwRRfWEHLddG54RCjTD30RlmoZj13Zfg7dSVLVpVOkLm5F3I8n0Zd8aQ6eQopa6J7AGAutEYH2dkQ9I1QkS21qnF932qx60RKvoLYOZ1dFZ3oTGOgNYMO6jrEByREZeIU90XyM6KadeSgFuCPiWMiNvEwSqJwqJGaoMACVsdDWDPJ1Bglq5-fDIdz2o9U7_FcKMvJ6G8UtMVWtDd0gwjKtGKJWRp72YTEhX2B-xlICHmgnQjCrzkfb7t9T0W2EFMhMn_5_Wc3K37KU6Z9UpOd5vD-EFeE17-zIpxB_ufBaJ priority: 102 providerName: ProQuest |
Title | Case series and review of Ayurvedic medication induced liver injury |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33714265 https://www.proquest.com/docview/2502619034/abstract/ https://search.proquest.com/docview/2501479577 https://pubmed.ncbi.nlm.nih.gov/PMC7956115 https://doaj.org/article/7fdb1e618fcb49e9bcad4714df636f95 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9xADBZJCiGX0HfcplsXCj0UZ23Pyz7uLgmhsCGEBpZeBs-rTUi8YR-F5tdXM7aXNbnlYrBHNjPSJ0vySDLAV50XmXO5TaggVUJVhe9Bx8skNZnirtSZcn5Hd3rBz6_pjxmb7QDramFC0r5WNyf13f1JffMn5FY-3Othlyc2vJxOhK_GzNhwF3YFIVsh-m3o35IRQVhXIFPw4dJ_a_Gptj55CO158ngA-8S3qsu9TdmyR6Ft_9OX85Z16mdObpmis5dw2PqQ8aiZ6yvYsfVr2J-2u-RvYDJB0xR7bNllXNUmbupT4rmLR__Wi7-eMA6b6kEsMYblKGAT3_kcDTy7RT6_heuz05-T86T9WUKiWUlXiShSozGWyK0zVDCjK26Y1ZaTynCGMshVRpxm1iLrXKmM8CWw1mK4hkJhKXkHe_W8tkcQCzTi-BgnqrKkvl27KdBNSUlRlSI3qYrge8cy-dD0xJAhlii4bHgtkdcy8Fo-RjD2XN1Q-n7W4cJ88Vu2UpXCGZXhzAqnFS1tqXSFq8iocZwgZFgEn71MZFMcutFKOeIM_Q90KnkE3wKF10sUja7a8gJcku9w1aM87lGiPun-cCd32erzUqKj6EPNlNAIvmyG_Z0-R62283WgyShCU4gI3jcw2Sy6Q1sEogegHlf6Iwj-0O27BfuHZ9_5EQ7yBvtJRo5hb7VY20_oSa3UAPVnJgbwYnx6cXk1CN8j8Hg1_jUIOvUf6b0g-g |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1ra9RAcNErqF_Et9FqVxD8IKHZZB_JJ7keLaf2DpEW-m3JvnwgSb2HYH-9M8lebBD8mOwk7M5jZ2bnsYS8tnnJQsh9ylVRp9zUsA8GWaWZY0aGyjITMKK7WMr5Of9wIS7igds6plXu9sRuo3atxTPyQ1DVaOxnBX93-TPFW6Mwuhqv0LhJ9ngBrsqE7B0dLz99HuII2NBpVypTysM1nrpg0i2mEYFmT69G6qjr2v_v3nxNOY0TJ69popN75G40Iem0p_l9csM3D8itRQySPySzGWgmiqzl17RuHO3LU2gb6PT3dvULAWkXU--oQsErB_o6-gNTNODpO6D5ETk_OT6bzdN4V0JqRcU3qSozZ8GVyH1wXAlna-mEt14WtZMCSJAbVgQrvJeMhco4hRWw3oO3BjQRWfGYTJq28U8JBZzhb4Kqq4pjt3ZXgpWSFWVdqdxlJiFvdyjTl31LDN25EqXUPYI1IFh3CNZXCTlCrA6Q2M66e9GuvugoHVoFZxjMrAzW8MpXxtawCsZdkAVwjEjIAdJE97Whg1DqqRRgfoBNKRPypoNAsQTS2DpWF8CSsMHVCHJ_BAniZMfDO7rrKM5r_Zf5EvJqGMYvMUWt8e22g2FcVUKphDzp2WRYdIF9EXMJ61AjBhphZTzSfPvaNftWWHnMxLP_T-uA3J6fLU716fvlx-fkTt5zeMqKfTLZrLb-BVhOG_MyiscfjdMXIg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB5BkaJeyhsMhRoJiQNy_Fjvrn0Mgag8UvVApYrLyvuCvpwoDyTy65ld21EMtx6THUcef9_szGRnxgBvVVak1mYmyjmpolxWuA9aVkaJTiWzpUqldSe60xN2fJZ_OafnO6_68kX7Sl4M6-ubYX3xy9dWzm9U3NWJxafTMXfdmCmN59rGd-Ee2mxW7iTql36KS0o4oV2bTMHipfvHxRXcuhIi9OrRZh8GxA2sy5xn2fFKfnj__1v0jo_q10_uOKTJffjRqdLUoVwN1ys5VJt_pjzeStcHcNCGqeGoEXkId0z9CAbT9iD-MYzH6P1CR1-zDKtah00LTDiz4ejPevHbCYb-3N4jH2LmjxzS4bUrA8FPlwjlEzibfPo-Po7a9zFEipb5KuJFohWmK5mxOudUq4ppapRhpNKMIsyZTIlV1Bi8Y1tKzV2XrTGYESLuNCFPYa-e1eY5hBzjBPwZy6uyzN1EeF1gJJSQoip5phMZwPsODzFvxm4In64UTDRACgRSeCDFJoAPDrKtpBuZ7b-YLX6K9mEKbrVM8c4Kq2RemlKqCrVIc20ZQVbSAI4c4KLpP90avhgxiiEOxq0sgHdewpk-4q6qtoMBVXJDtHqShz1JNFnVX-5IJdotYykwFnXZbELyAN5sl92VrgyuNrO1l0lzZATnATxrOLhVuqNyALzHzt5T6a8g5_xA8ZZjL2595REMTj9OxLfPJ19fwn7W2FiUkkPYWy3W5hXGbSv52lvoXzbVQO8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Case+series+and+review+of+Ayurvedic+medication+induced+liver+injury&rft.jtitle=BMC+complementary+medicine+and+therapies&rft.au=Karousatos%2C+Christopher+M&rft.au=Lee%2C+Justin+K&rft.au=Braxton%2C+David+R&rft.au=Fong%2C+Tse-Ling&rft.date=2021-03-13&rft.eissn=2662-7671&rft.volume=21&rft.issue=1&rft.spage=91&rft_id=info:doi/10.1186%2Fs12906-021-03251-z&rft_id=info%3Apmid%2F33714265&rft.externalDocID=33714265 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2662-7671&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2662-7671&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2662-7671&client=summon |